1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Individual perspectives on outcomes in Diabetes
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
Patient-reported outcome and experience measures for diabetes : development of scale models, differences between patient groups and relationships with cardiovascular and diabetes complication risk factors, in a combined registry and survey study in Sweden
(
- Contribution to journal › Article
- 2018
-
Mark
A disease-specific questionnaire for measuring patient-reported outcomes and experiences in the Swedish National Diabetes Register : Development and evaluation of content validity, face validity, and test-retest reliability
(
- Contribution to journal › Article
- 2016
-
Mark
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease : Are Current Models Suitable to Evaluate Personalized Medicine?
(
- Contribution to journal › Article
- 2015
-
Mark
Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden.
(
- Contribution to journal › Article
-
Mark
Cost-Effectiveness and Heterogeneity: Using Finite Mixtures of Disease Activity Models to Identify and Analyze Phenotypes
2015) In Working Paper / Department of Economics, School of Economics and Management, Lund University(
- Working paper/Preprint › Working paper
- 2014
-
Mark
Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease: Cross-Model Comparison of Hypothetical Treatment Scenarios
(
- Contribution to journal › Article
-
Mark
Obesity and Surgical Treatment - A Cost-Effectiveness Assessment for Sweden
(
- Contribution to journal › Article
- 2010
-
Mark
A maximum likelihood estimator of a Markov model for disease activity in Crohn's disease and ulcerative colitis for annually aggregated partial observations.
(
- Contribution to journal › Article
- 2009
-
Mark
A Cost Effectiveness Analysis Of A General Vaccination Programme With The New 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein-D Conjugate Vaccine (Phid-Cv) In Sweden
(
- Contribution to journal › Published meeting abstract